Brief: Mymd Pharmaceuticals Inc Awaits Receipt Of Data From Phase 2 Trial For MYMD-1

Q/C Technologies

14/07/2023 13:33

July 14 (Reuters) - MyMD Pharmaceuticals Inc  MYMD.O :
    * MYMD PHARMACEUTICALS INC- STILL AWAITING RECEIPT OF DATA
FROM
THE PHASE 2 TRIAL FOR MYMD-1® IN SARCOPENIA THAT WAS COMPLETED
IN JUNE 2023.

Further company coverage:  MYMD.O 

 ((Reuters.Briefs@thomsonreuters.com;))